Sort
82,697 grants matching “vaccine development”
Immunology of Acute and Chronic Viral Hepatitis
$754,276Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Syrian hamsters as an animal model for influenza virus research
$754,269Yoshihiro Kawaoka · University Of Wisconsin-Madison · R01 · FY2022 · AI
Task A85 Mouse and Guinea Pig Models for Herpesviruses
$754,237David Bernstein · Cincinnati Childrens Hosp Med Ctr · N01 · FY2016 · AI
Psychological symptoms in healthcare workers following the COVID-19 pandemic and relationship to long-term cardiovascular risk
$754,214Bernard P. Chang · Columbia University Health Sciences · R01 · FY2025 · HL
Evolution of anti-filovirus B cell responses and mechanisms of protection
$754,197M. Javad Aman · Integrated Biotherapeutics, Inc. · R01 · FY2017 · AI
Human Cytomegalovirus Entry into Cells Mediated by Pentamer and Trimer Complexes
$754,173David C. Johnson · Oregon Health & Science University · R01 · FY2021 · AI
Human Cytomegalovirus Entry into Cells Mediated by Pentamer and Trimer Complexes
$754,173David C. Johnson · Oregon Health & Science University · R01 · FY2022 · AI
Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi
$754,130Linden T Hu · Tufts University Boston · R01 · FY2023 · AI
Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants
$754,126Martha A. Alexander-Miller · Wake Forest University Health Sciences · R01 · FY2020 · AI
Development of a Recombinant Tetravalent Dengue Vaccine Based on a Subunit Envelo
$754,080Ge Liu · Vaxinnate Corporation · R01 · FY2015 · AI
The Impact of Pre-exisiting SIV on Host Immunity to M tuberculosis in Macaques
$754,049Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · AI
Task A05: Small animal models for cytomegalovirus and herpes simplex viruses
$753,986David Bernstein · Cincinnati Childrens Hosp Med Ctr · N01 · FY2020 · AI
Immunity to Pneumonic Tularemia
$753,972Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
CD4 T cell-targeted nanoparticle in vivo delivery of CRISPR/Cas9 genome editors for HIV cure
$753,945Wenhui Hu · Temple Univ Of The Commonwealth · R01 · FY2021 · AI
METAGENOMICS OF ENTERIC DISEASE IN SIV-INFECTED AND UNINFECTED MACAQUES
$753,932Herbert W Virgin · Washington University · R01 · FY2014 · OD
Preclinical studies of a Cryptococcus vaccine for AIDS patients
$753,820Jennifer K. Lodge · Duke University · R01 · FY2022 · AI
AN AIDS-RELATED CRYPTOCOCCUS NEOFORMANS GENOME CENTER
$753,798Stanford University · U01 · FY2001 · AI
VIOLIN 2.0: Vaccine Information and Ontology LInked kNowledgebase
$753,786Yongqun He · University Of Michigan At Ann Arbor · U24 · FY2022 · AI
Evolutionary multispecies transcriptomics to reveal genes that govern fungal spore germination and pathogenesis
$753,774Jeffrey Peter Townsend · Yale University · R01 · FY2022 · AI
Defining the impact of host factors on the molecular architecture and bacterial physiology of Staphylococcus aureus abscesses
$753,739James E Cassat · Vanderbilt University Medical Center · R01 · FY2022 · AI
Immune diagnostics and vaccine targets: breast cancer antigens from mice to women
$753,681Mary L. Disis · University Of Washington · U01 · FY2012 · CA
HIV VACCINE CLINICAL TRIALS UNIT
$753,641Peter F Wright · Vanderbilt University · U01 · FY2006 · AI
Characterizing the therapeutic efficacy of CD8 T cell responses induced by the IL-15 superagonist ALT-803
$753,619Shelby L Oconnor · University Of Wisconsin-Madison · R01 · FY2021 · AI
Antibody-based therapeutic strategy for New World mammarenavirus hemorrhagic fever
$753,610Manuel L Penichet · University Of California Los Angeles · R01 · FY2024 · AI
Vaccine Efficacy of Modified HIV Envelopes
$753,600Leonidas A Stamatatos · Seattle Biomedical Research Institute · R01 · FY2007 · AI